STI-571的结构机制是抑制阿贝尔森氨酸激酶的抑制
T Schindler1, W Bornmann, P Pellicena
1Laboratories of Molecular Biophysics and Howard Hughes Medical Institute, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA.
像STI-571这样的阿贝尔森氨酸激酶 (Abl) 抑制剂可以治疗慢性骨髓性白血病 (CML). 晶体结构显示STI-571通过稳定非活性激酶构造来结合Abl,这对于向药物设计至关重要.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 在瘤学瘤学.
背景情况:
- 阿贝尔森氨酸激酶 (Abl) 的过度活动驱动慢性骨髓性白血病 (CML).
- STI-571是一种有效的小分子抑制剂用于CML治疗.
研究的目的:
- 为了阐明STI-571抑制Abl酶的结构基础.
- 了解底层Abl激酶失活的构造变化.
主要方法:
- 使用X射线晶体学来确定Abl催化域的结构.
- 该结构与STI-571抑制剂的一种变体综合分析.
主要成果:
- 晶体结构显示,STI-571结合会诱导一个不活跃的Abl形态.
- 一个关键的特征是无酸化的"激活循环"在一个独特的形状.
- 这种非活性构造不同于活性激酶和相关的Src激酶.
结论:
- 通过利用ABL独特的失活机制,STI-571实现了高亲和度和特异性.
- 准独特的失活路径为开发特定的激酶抑制剂提供了一种策略.
更多相关视频
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
09:31PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
Published on: September 26, 2020
相关概念视频
Enzyme Inhibition
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Production of Pharmaceuticals
Inhibitors of Bacterial Protein Synthesis
